Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-11-15
Original SEC Filing: Click here

---

Webplus: BSPM/20101115/8-K_1/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS, INC. REPORTS THIRD QUARTER REVENUE INCREASE OF 29.7% TO $20.2 MILLION XIANYANG, China, November 15, 2010 (Xinhua-PRNewswire-FirstCall) , – Q3 2010 revenue increased 29.7% to $20.2 million – Q3 2010 Non-GAAP adjusted net income increased 11.9% to $3.5 million with Non-GAAP adjusted EPS of $0.13 – Cash and cash equivalents totaled $16.6 million at September 30 – $8.7

---

---

Webplus: BSPM/20101115/8-K_1/1/000.htm SEC Original: biostarpharma8k111510.htm
FORM 8-K CURRENT REPORT November 15, 2010 Date of report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 (Issuer Telephone Number) N/A (Former name or former address, if

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-11-15CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046